[1］NOWOTNY M， GAIDAMAKOV S A， CROUCH R J，et al.Crystal structures of RNase H bound to an RNA/DNA hybrid： substrate specificity and metal-dependent catalysis[J］.Cell，2005，121(7)：1005-1016. [2］DAVIES J F， HOSTOMSKA Z， HOSTOMSKY Z，et al.Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase[J］. Science， 1991， 252(5002)：88-95. [3］HUANG H，CHOPRA R，VERDINE G L.Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase： implications for drug resistance[J］.Science，1998，282(5394)：1623-1625. [4］PARI K， MUELLER G A， DEROSE E F，et al.Solution structure of the RNase H domain of the HIV-1 reverse transcriptase in the presence of magnesium?[J］.Biochemistry， 2003， 42(3)： 639-650. [5］ZENG Q P.Human Aids[M］.Ver 2.Beijing： People Sanitation Press，2001：81-82. [6］WISNIEWSKI M，BALAKRISHNAN M，PALANIAPPAN C，et al.Unique progressive cleavage mechanism of HIV reverse transcriptase RNase H[J］.Proc Natl Acad Sci USA，2000， 97(22)：11978-11983. [7］WISNIEWSKI M，CHEN Y，BALAKRISHNAN M，et al.Substrate requirements for secondary cleavage by HIV-1 reverse transcriptase RNase H[J］. J Biol Chem，2002，277(32)： 28400-28410. [8］KLUMPP K，HANG J Q，RAJENDRAN S，et al.Two-metal-ion mechanism of RNA cleavage by HIV RNase H and mechanism based design of selective HIV RNase H inhibitors[J］. Nucleic Acids Res，2003， 31(23)：6852-6859. [9］CRISTOFARO J V，RAUSCH J W，LE GRICE S F，et al. Mutations in the Ribonuclease H active site of HIV-RT reveal a role for this site in stabilizing enzyme-primer-template binding[J］. Biochemistry， 2002， 41(36)： 10968-10975. [10］COWAN J A，OHYAMA T，HOWARD K.Metal-ion stoichiometry of the HIV-1 RT ribonuclease H domain： evidence for two mutually exclusive sites leads to new mechanistic insights on metal-mediated hydrolysis in nucleic acid biochemistry[J］. J Biol Inorg Chem， 2000， 5(1)：67-74. [11］WITVROUW M， DE CLERCQ E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs[J］.Gen Pharmac，1997，29(4)：497-511. [12］DE CLERCQ E.Current lead natural products for the chemotherapy of Human Immunodeficiency (HIV) infection [J］. Med Res Rev，2000，20：323-349. [13］SARAFIANOS S G，CLARKJR A D，DAS K，et al.Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA[J］.The EMBO J， 2002，21(23)：6614-6624. [14］BORKOW G，FLETCHER R S，BARNARD J，et al. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone[J］. Biochemistry， 1997， 36(11)：3179-3185. [15］ZHANG Y.The recent development of HIV chemotherapy[J］. World Notes Antibiof（国外医药抗生素分册），2005：26127-26132. [16］SHAW-REID C A，MUNSHI V，GRAHAM P，et al. Inhibition of HIV-1 ribonuclease H by a novel diketo acid， 4-[5-(benzoylamino)thien-2-yl］-2，4-dioxobutanoic acid[J］.J Biol Chem，2003， 278(5)：2777-2780. [17］METIFIOT M，LEON O，TARRAGO-LITVAK L，et al.Targeting HIV-1 integrase with aptamers selected against the purified RNase H domain of HIV-1 RT[J］.Biochimie， 2005，87(9-10)：911-919. [18］DE SOULTRAIT V R， LOZACH P Y， ALTMEYER R，et al. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents[J］. J Mol Biol， 2002，324(2)：195-203. [19］HANNOUSH R N，CARRIERO S，MIN K L， et al. Selective inhibition of HIV-1 reverse transcriptase (HIV-1 RT) RNase H by small RNA hairpins and dumbbells[J］. Chem Bio Chem，2004，5(4)：527-533. [20］GABBARA S，DAVIS W R，HUPE L，et al.Inhibitors of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase[J］. Biochemistry，1999，38(40)：13070-13076. [21］DAVIS W R，TOMSHO J，NIKAM S，et al. Inhibition of HIV-1 reverse transcriptasecatalyzed DNA strand transfer reactions by 4-chlorophenylhydrazone of mesoxalic acid[J］.Biochemistry，2000，39(46)：14279-14291. [22］BUDIHAS S R，GORSHKOVA I，GAIDAMAKOV S，et al.Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones[J］. Nucl Acid Res，2005， 33(4)：1249-1256. [23］HANG J Q，RAJENDRAN S，YANG Y，et al.Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides[J］. Biochem Biophys Res Commun，2004，317(2)：321-329. [24］TARRAGO-LITVAK L， ANDREOLA M L， FOURNIER M， et al. Inhibitors of HIV-1 reverse transcriptase and integrase： classical and emerging therapeutical approaches[J］.Curr Pharm Des，2002，8(8)：595-614. [25］GROBLER J A，STILLMOCK K，HU B，et al.Diketo acid inhibitor mechanism and HIV-1 integrase： implications for metal binding in the active site of phosphotransferase enzymes[J］. Proc Natl Acad Sci USA， 2002，99(10)：6661-6666. [26］TRAMONTANO E，ESPOSITO F，BADAS R， et al. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)］-2，4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro[J］. Antiviral Res，2005，65(2)：117-124. [27］MIN B S，MIYASHIRO H，HATTORI M，et al.Inhibitory effects of quinones on RNase H activity associated with HIV-1 reverse transcriptase[J］.Phytother Res，2002，16：57-62. [28］PARNIAK M A，MIN K L，BUDIHAS S R，et al.A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity[J］. Biochemistry，2005，322(1)：33-39. [29］SHAW-REID C A，FEUSTON B，MUNSHI V，et al.Dissecting the effects of DNA polymerase and Ribonuclease H inhibitor combinationson HIV-1 reverse-transcriptase activities[J］. Biochemistry，2005， 44(5)：1595-1606.